Abstract:The bacterial ghost (BG) system is a novel vaccine delivery system endowed with intrinsic adjuvant properties. Bacterial ghosts are nonliving Gram-negative bacterial cell envelopes devoid of cytoplasmic contents while maintaining their cellular morphology and native surface antigenic structures. They are produced by PhiX174 protein E-mediated lysis of Gram-negative bacteria, and can induce humoral and cellular immune response, including mucosal immune responses. Plasmid pElysis consisting E gene was transformed into AhJ-1. Through shifting the culture temperature from 28 degrees C to 42 degrees C, A. hydrophila J-1 (pElysis) was induced to lyse and the OD600 value of culture media was measured every 15 minutes during the induction. The lysed bacteria were observed by scanning electron microscopy (SEM). The A. hydrophila ghosts (AHG) used as oral vaccine were also investigated. The OD600 value of A. hydrophila J-1(pElysis) began to decline after 30 min of induction, and after 75 min of induction, the OD600 value decline speed become slowly. The efficiency of ghost induction in non-lyophilized A. hydrophila was 99.99%, 16 hours post induced, no live bacteria can be detected in culture. Scanning electron microscopy observation proved that most lysed bacteria were emptied. Fish vaccination experiments shows that the antibody evoked highest degree after 5 weeks by oral administration of bacterial ghost vaccine and the agglutination antibody titer reached 2(7) and continued two weeks, while the agglutination antibody titer of formalin killed vaccine only reached 26 and only maintained one week. After challenged with the parent strain J-1, the survival rate of bacterial ghost vaccinated fish was higher than the control group and formalin killed vaccine group, the relative percent survival (RPS) was 78.95% (16/20), but the RPS of formalin killed vaccine group was 57.9% (12/20). This suggests that the bacterial ghost vaccine has higher potential to induce protective adaptive immunity than normal vaccine.

Preparation and Experimental Immunity of Actinobacillus Pleuropneumoniae Ghost Vaccine

Protection of Piglets by A Haemophilus Parasuis Ghost Vaccine Against Homologous Challenge

Humoral immunity is the primary means of heterologous <i>Propionibacterium acnes</i> vaccination against<i> Actinobacillus </i> <i>pleuropneumoniae</i> infection in pig

Evaluation of Immunogenicity and Protective Efficacy of Actinobacillus Pleuropneumoniae HB04C− Mutant Lacking a Drug Resistance Marker in the Pigs

Potential Use an Actinobacillus Pleuropneumoniae Double Mutant Strain ΔapxIICΔapxIVA As Live Vaccine That Allows Serological Differentiation Between Vaccinated and Infected Animals

Protective Efficacy and Immunologic Mechanism of the Recombinant Subunit Vaccine Against Actinobacillus Pleuropneumoniae in Mice

Protective Efficacy of a Genetic Subunit Bacterin against Actinobacillus pleuropneumoniae in Mice

Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.

A Combinatorial Vaccine Containing Inactivated Bacterin and Subunits Provides Protection Against Actinobacillus Pleuropneumoniae Infection in Mice and Pigs

Study on immunogenicity of the three gene-deleted mutant strains of Actinobacillus pleuropneumoniae

Immunoprotective Efficacy of Six in Vivo-Induced Antigens Against Actinobacillus Pleuropneumoniae As Potential Vaccine Candidates in Murine Model.

Generation of Porcine Pasteurella Multocida Ghost Vaccine and Examination of Its Immunogenicity Against Virulent Challenge in Mice.

Study on Preparation of a Streptococcus Suis Ghost Vaccine

Potentiation of Immunity of Piglets to Mycoplasma Hyopneumoniae Vaccine with Fused Gene for Pig IL-4 and IL-6 Embodied in Chitosan Nanoparticles

Protective Efficacy of Recombinant Subunit Vaccines Against Actinobacillus Pleuropneumoniae in Mice

Immuneactivity of Propionibacterium Acnes Against Actinobacillus Pleuropneumoniae Serotype 7 and 9 Infection in Mice

Preparation of an Inactivated Combined Vaccine Against Swine Streptococcosis

Positive Role for Rapxivn in the Immune Protection of Pigs Against Infection by Actinobacillus Pleuropneumoniae

Phenotypic characteristics and protective efficacy of an attenuated Mycoplasma hyopneumoniae vaccine by aerosol administration

[Cloning and Expression of Hemolytic-Toxin from Actinobacillus Pleuropneumoniae and the Immunoprotection in Mice].

[Generation of Aeromonas Hydrophila Ghosts and Their Evaluation As Oral Vaccine Candidates in Carassius Auratus Gibelio].